IE46957B1 - New peptide derivatives - Google Patents

New peptide derivatives

Info

Publication number
IE46957B1
IE46957B1 IE1227/78A IE122778A IE46957B1 IE 46957 B1 IE46957 B1 IE 46957B1 IE 1227/78 A IE1227/78 A IE 1227/78A IE 122778 A IE122778 A IE 122778A IE 46957 B1 IE46957 B1 IE 46957B1
Authority
IE
Ireland
Prior art keywords
compounds
ser
formula
group
acid
Prior art date
Application number
IE1227/78A
Other languages
English (en)
Other versions
IE781227L (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IE781227L publication Critical patent/IE781227L/xx
Publication of IE46957B1 publication Critical patent/IE46957B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069—Ser-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IE1227/78A 1977-06-20 1978-06-19 New peptide derivatives IE46957B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77584 1977-06-20

Publications (2)

Publication Number Publication Date
IE781227L IE781227L (en) 1978-12-20
IE46957B1 true IE46957B1 (en) 1983-11-16

Family

ID=19728618

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1227/78A IE46957B1 (en) 1977-06-20 1978-06-19 New peptide derivatives

Country Status (18)

Country Link
EP (1) EP0000330B1 (fr)
JP (2) JPS549224A (fr)
AT (1) AT364095B (fr)
AU (1) AU525005B2 (fr)
CA (1) CA1139305A (fr)
DD (1) DD139257A5 (fr)
DE (1) DE2860893D1 (fr)
DK (1) DK275178A (fr)
ES (3) ES470961A1 (fr)
FI (1) FI781933A (fr)
GR (1) GR71681B (fr)
IE (1) IE46957B1 (fr)
IL (1) IL54950A (fr)
NO (1) NO148921C (fr)
NZ (1) NZ187611A (fr)
PL (3) PL216739A1 (fr)
PT (1) PT68188A (fr)
ZA (1) ZA783504B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014815A3 (fr) * 1978-12-20 1980-10-29 Ciba-Geigy Ag Dérivés peptidiques, procédé pour leur préparation et intermédiaires, et compositions pharmaceutiques contenant un de ces composés
DE3485094D1 (de) * 1983-01-25 1991-10-31 Ciba Geigy Ag Neue peptidderivate.
FR2546164B1 (fr) * 1983-05-16 1987-07-17 Centre Nat Rech Scient Nouveaux derives de peptides, leur preparation et leur application comme inhibiteurs de l'elastase
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
DE3546150A1 (de) * 1985-06-24 1987-01-22 Hoechst Ag Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
DE3522638A1 (de) * 1985-06-25 1987-01-08 Diamalt Ag Neue somatostatin-derivate
FR2611205B1 (fr) * 1987-02-20 1990-03-02 Serbio Dipeptides, procede de preparation et utilisation dans le dosage de proteases
EP0306912A3 (fr) * 1987-09-08 1989-07-05 Albany Medical College Ensemble immunogène capable de provoquer sélectivement la production d'anticorps et compositions pharmaceutiques l'utilisant.
DE4119856A1 (de) * 1991-06-17 1992-12-24 Hoechst Ag N-acyl-s-(2-hydroxyalkyl)-cysteine, deren herstellung sowie deren verwendung als zwischenprodukte zur herstellung von synthetischen immunadjuvantien und synthetischen impfstoffen
ES2096064T3 (es) * 1991-12-19 1997-03-01 Ciba Geigy Ag Derivados del acido aminosulfonico y procedimiento para su obtencion.
AU666789B2 (en) * 1992-12-28 1996-02-22 Takeda Chemical Industries Ltd. 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof
EP0604945A1 (fr) 1992-12-28 1994-07-06 Takeda Chemical Industries, Ltd. TAN-1511, dérivés, préparation et utilisation
EP0641776A3 (fr) * 1993-09-08 1997-05-02 Takeda Chemical Industries Ltd Dérivés de thioglycérol.
GB9930591D0 (en) * 1999-12-23 2000-02-16 Univ London Component for vaccine
DE10048840A1 (de) * 2000-10-02 2002-04-11 Biotechnolog Forschung Gmbh Verwendung von Lipopeptiden oder Lipoproteinen zur Behandlung von Lungeninfektionen und -tumoren
FR2816060A1 (fr) * 2000-10-27 2002-05-03 Pf Medicament Procede d'identification de nouvelles molecules se liant au recepteur lox et utilisation de ces molecules
EA014644B1 (ru) 2005-06-13 2010-12-30 Кливлэнд Биолабс Инк. Способы защиты от апоптоза с применением липопептидов
EP1909813A4 (fr) * 2005-07-25 2009-09-09 Therimunex Llc Diacylglycerides peptidyle
DE102016005550A1 (de) 2016-05-09 2017-11-09 Emc Microcollections Gmbh Adjuvans zur lnduzierung einer zellulären lmmunantwort
MX2020004742A (es) * 2017-11-06 2020-08-13 Crown Equip Corp Sistema de colocacion lateral de vehiculo industrial.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2706490A1 (de) 1976-02-20 1977-08-25 Ciba Geigy Ag Neue carbonsaeureester

Also Published As

Publication number Publication date
NO148921C (no) 1984-01-11
DE2860893D1 (en) 1981-11-05
FI781933A (fi) 1978-12-21
ZA783504B (en) 1979-06-27
ATA445178A (de) 1981-02-15
GR71681B (fr) 1983-06-21
PL216739A1 (fr) 1980-05-19
NO782138L (no) 1978-12-21
ES470961A1 (es) 1980-03-01
PL216740A1 (fr) 1980-05-19
ES478717A1 (es) 1979-12-16
JPS549224A (en) 1979-01-24
JPS6372671A (ja) 1988-04-02
IL54950A (en) 1983-10-31
IL54950A0 (en) 1978-08-31
CA1139305A (fr) 1983-01-11
PT68188A (de) 1978-07-01
JPS6360760B2 (fr) 1988-11-25
AU3723078A (en) 1980-01-03
EP0000330A1 (fr) 1979-01-24
IE781227L (en) 1978-12-20
PL207766A1 (pl) 1979-11-19
NO148921B (no) 1983-10-03
JPS641466B2 (fr) 1989-01-11
EP0000330B1 (fr) 1981-08-05
ES478718A1 (es) 1979-12-16
AU525005B2 (en) 1982-10-14
NZ187611A (en) 1981-07-13
DD139257A5 (de) 1979-12-19
AT364095B (de) 1981-09-25
DK275178A (da) 1978-12-21

Similar Documents

Publication Publication Date Title
US4439425A (en) Peptide derivatives
IE46957B1 (en) New peptide derivatives
CA1247089A (fr) Derives de peptides
PL131613B1 (en) Process for preparing novel lipophilic muramylpeptides
IE50899B1 (en) Oligopeptide derivatives of aldohexoses,intermediates,processes for their manufacture,preparations containing such compounds and their use
US4442031A (en) Immunopotentiating peptides
US4390528A (en) Tuftsinyl-tuftsin
NZ223509A (en) Tuftsin analogues containing a bicyclic nitrogen-containing residue and pharmaceutical compositions
US3749703A (en) Asn15-bovine thyrocalcitonin
US5041535A (en) Antileukemic and immunostimulant peptides
US4487763A (en) Peptide, process for preparation thereof and use thereof
AU721261B2 (en) Peptide inhibitors of hematopoietic cell proliferation
US4487764A (en) New peptides and a process for their preparation
HU184041B (en) Process for preparing glucopyranosyl-peptides
GB2185486A (en) Conjugate of alpha-melanotropin with p-L-sarcolysine (melphalan)
US4672106A (en) Muramylpeptide active ester derivatives
US5112811A (en) Sdk peptides and therapeutic compositions containing them
US4354966A (en) Peptides, process for preparation thereof and use thereof
JPH0672152B2 (ja) チモシンα１―フラグメント及び該化合物を含有する免疫調節剤
EP0050856B1 (fr) Nouveau peptide, procédé pour sa préparation et composition pharmaceutique le contenant
JPH0363559B2 (fr)
US5656601A (en) Acylated splenopentins, methods for their synthesis and their use
KR840000010B1 (ko) 무라밀디펩타이드 유도체의 제조방법
IL46238A (en) Process for the purification of synthetically produced calcitonins
AT398765B (de) Verfahren zur herstellung von neuen lipopeptiden